fda deadline tirzepatide Meridian FDA Updates on Compounded GLP-1

But the annual cost of these drugs in the US upwards of $11,000 at recent list prices, though net prices may be lower with rebates negotiated by pharmacy benefit managers has raised concerns about the fiscal impact of broad coverage of GLP-1 drugs on Medicare, other health insurers, and patients

And they can survive eating only a few meals per year

One of the most consistent patterns I see is patients who come to us specifically because they couldnt tolerate semaglutide elsewhere typically due to nausea

Reason #4: We dont know enough yet This is perhaps the most honest reason: the absence of data isnt the same as data showing safety

While clinical trials demonstrate significant efficacy, some patients experience suboptimal results or apparent treatment failure